Insights About Cannabis and Psychosis Using Video Games for Young People With a First Episode of Psychosis, Particularly Those From Black Racialized Communities: Protocol for a Mixed Methods Study.
Black youth
cannabis use
first-episode psychosis
knowledge translation
video games
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
20 May 2022
20 May 2022
Historique:
received:
28
02
2022
accepted:
28
03
2022
revised:
26
03
2022
pubmed:
8
4
2022
medline:
8
4
2022
entrez:
7
4
2022
Statut:
epublish
Résumé
Cannabis use disorder among young people with a first episode of psychosis contributes to relapse, hospitalization, and impaired functioning. However, few studies have examined what young people with early phase psychosis, particularly those from Black racialized communities, understand or appreciate about this relationship, even though they may be at risk. There are no formally tested knowledge translation strategies that disseminate these research findings for young people with emerging psychosis from Black racialized communities. This study aims to conceptualize what young people with early phase psychosis/cannabis use disorder understand about the relationship between cannabis and psychosis, focusing on people from racialized backgrounds. This study also aims to assess whether the knowledge translation product, the "Back to Reality Series," increases awareness of the impact of cannabis use on psychosis from the perspectives of young people with emerging psychosis and cannabis use disorder from Black African and Caribbean communities. Qualitative analysis will reveal themes from qualitative interviews about cannabis and psychosis from the perspectives of young people with emerging psychosis and cannabis use disorder from Black African and Caribbean communities. Perceptions before and after exposure to the Back to Reality Series will be qualitatively analyzed. A control game will be used for comparison, and scores on a quiz after playing the Back to Reality Series will be quantitatively analyzed to establish whether the Back to Reality Series raises awareness of the effects of cannabis on psychosis. An advisory council involving young people from Black communities, family members, and clinicians will bring community perspectives to this research. We began recruiting participants for this study in September 2021. We will complete data collection on demographic and clinical factors, qualitative interviews, and quantitative assessments of the Back to Reality Series. The voices of young people from racialized backgrounds will generate preliminary data to inform early psychosis programs, addressing cannabis use in this population. The findings may advance the use of a new knowledge translation product that deals with gaps in knowledge about cannabis use for people experiencing early phase psychosis, particularly those from racialized communities. DERR1-10.2196/36758.
Sections du résumé
BACKGROUND
BACKGROUND
Cannabis use disorder among young people with a first episode of psychosis contributes to relapse, hospitalization, and impaired functioning. However, few studies have examined what young people with early phase psychosis, particularly those from Black racialized communities, understand or appreciate about this relationship, even though they may be at risk. There are no formally tested knowledge translation strategies that disseminate these research findings for young people with emerging psychosis from Black racialized communities.
OBJECTIVE
OBJECTIVE
This study aims to conceptualize what young people with early phase psychosis/cannabis use disorder understand about the relationship between cannabis and psychosis, focusing on people from racialized backgrounds. This study also aims to assess whether the knowledge translation product, the "Back to Reality Series," increases awareness of the impact of cannabis use on psychosis from the perspectives of young people with emerging psychosis and cannabis use disorder from Black African and Caribbean communities.
METHODS
METHODS
Qualitative analysis will reveal themes from qualitative interviews about cannabis and psychosis from the perspectives of young people with emerging psychosis and cannabis use disorder from Black African and Caribbean communities. Perceptions before and after exposure to the Back to Reality Series will be qualitatively analyzed. A control game will be used for comparison, and scores on a quiz after playing the Back to Reality Series will be quantitatively analyzed to establish whether the Back to Reality Series raises awareness of the effects of cannabis on psychosis. An advisory council involving young people from Black communities, family members, and clinicians will bring community perspectives to this research.
RESULTS
RESULTS
We began recruiting participants for this study in September 2021. We will complete data collection on demographic and clinical factors, qualitative interviews, and quantitative assessments of the Back to Reality Series.
CONCLUSIONS
CONCLUSIONS
The voices of young people from racialized backgrounds will generate preliminary data to inform early psychosis programs, addressing cannabis use in this population. The findings may advance the use of a new knowledge translation product that deals with gaps in knowledge about cannabis use for people experiencing early phase psychosis, particularly those from racialized communities.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
DERR1-10.2196/36758.
Identifiants
pubmed: 35389874
pii: v11i5e36758
doi: 10.2196/36758
pmc: PMC9166641
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e36758Informations de copyright
©Suzanne Archie, Lena Palaniyappan, Andrew T Olagunju, Natasha Johnson, Nicole Kozloff, Elham Sadeh, Andrea Bardell, Alexandra Baines, Kelly K Anderson, Oyedeji Ayonrinde, Manuela Ferrari. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 20.05.2022.
Références
JMIR Form Res. 2022 Jun 20;6(6):e33693
pubmed: 35315782
J Clin Psychiatry. 2010 Mar;71(3):247-54
pubmed: 20331929
Lancet Psychiatry. 2017 Aug;4(8):627-633
pubmed: 28705600
Psychol Addict Behav. 2012 Jun;26(2):279-88
pubmed: 22149956
Schizophr Bull. 2010 Jul;36(4):688-701
pubmed: 18987101
CMAJ. 2015 Jun 16;187(9):E279-E286
pubmed: 25964387
Am J Addict. 2017 Apr;26(3):209-214
pubmed: 28295843
BMJ Open. 2015 Jan 14;5(1):e006562
pubmed: 25588783
Schizophr Bull. 2014 Nov;40(6):1194-7
pubmed: 25193975
Early Interv Psychiatry. 2018 Jun;12(3):339-347
pubmed: 27038079
Curr Pharm Des. 2012;18(4):542-9
pubmed: 22239586
Schizophr Bull. 2007 Nov;33(6):1354-63
pubmed: 17337748
Harm Reduct J. 2017 Jul 31;14(1):53
pubmed: 28760146
Schizophr Bull. 2014 Nov;40(6):1509-17
pubmed: 24345517
BMC Psychiatry. 2017 Dec 22;17(1):407
pubmed: 29273021
JMIR Res Protoc. 2020 Jun 24;9(6):e13834
pubmed: 32579117
Int J Environ Res Public Health. 2022 Feb 07;19(3):
pubmed: 35162872
J Can Acad Child Adolesc Psychiatry. 2017 Fall;26(3):184-189
pubmed: 29056980
Can J Psychiatry. 2015 May;60(5):223-31
pubmed: 26174526
Mol Psychiatry. 2018 May;23(5):1287-1292
pubmed: 28115737
Behav Cogn Psychother. 2012 Oct;40(5):529-41
pubmed: 22137185
Lancet. 2010 Oct 9;376(9748):1261-71
pubmed: 20933263
Early Interv Psychiatry. 2019 Aug;13(4):767-772
pubmed: 29542863
Lancet Psychiatry. 2015 Mar;2(3):233-8
pubmed: 26359901
Can J Psychiatry. 2007 Sep;52(9):563-71
pubmed: 17953160
Can J Psychiatry. 2020 Jun;65(6):426-435
pubmed: 32013556
Schizophr Bull. 2011 May;37(3):631-9
pubmed: 19915168
Front Psychiatry. 2017 Jan 10;7:215
pubmed: 28119636
Health Promot Chronic Dis Prev Can. 2020 Jun;40(5-6):176-183
pubmed: 32529977
Psychopathology. 2006;39(4):175-8
pubmed: 16636640
Curr Pharm Des. 2012;18(32):5105-12
pubmed: 22716137
Harm Reduct J. 2010 Sep 28;7:22
pubmed: 20920183
Acta Psychiatr Scand. 1994 Jan;89(1):62-7
pubmed: 7908156
Br J Psychiatry. 2010 Jun;196(6):447-53
pubmed: 20513854
Soc Sci Med. 2010 Apr;70(8):1141-7
pubmed: 20137846
Drug Alcohol Depend. 2017 Oct 1;179:93-99
pubmed: 28763781
Addict Behav. 1982;7(4):363-71
pubmed: 7183189
Biol Psychiatry. 2005 May 15;57(10):1117-27
pubmed: 15866551
Schizophr Res. 2017 Nov;189:91-96
pubmed: 28189531
J Fam Psychol. 2006 Mar;20(1):1-11
pubmed: 16569084
Psychiatr Serv. 2015 Jul;66(7):764-5
pubmed: 26130154
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
Acta Psychiatr Scand. 2007 Apr;115(4):304-9
pubmed: 17355521
Early Interv Psychiatry. 2013 May;7(2):193-9
pubmed: 22404861
Br J Psychiatry. 2009 Dec;195(6):488-91
pubmed: 19949195
J Am Med Inform Assoc. 2016 Jan;23(1):230-9
pubmed: 26186934
Schizophr Bull. 2008 Nov;34(6):1111-21
pubmed: 18723841